Statement of the problem: There has been significant progress in immune checkpoint inhibitor (ICI) therapy in using anti-PD-1 and or anti-CTLA-4 in many solid tumor types
cause and potential molecular events are not clearly explained. It was reported that immune cells may impact on matrix metalloproteinase pathway and IOP. The purpose of this study ... identify the key biomarkers and…
pointed at general mechanisms positively affected by precision nutrition in terms of modulating the immune system's responses to harmful stimuli, such as damaged cells, toxic compounds or uncontrolled cell ... remove…
Immune Checkpoint Inhibitors (ICIs) have emerged as a groundbreaking therapeutic modality in the field of oncology, offering new hope for patients with various types of cancer, including gynecological malignancies…